Abstract
Although the incidence of Crohn's disease is increasing, its pathogenesis remains unclear and no curative therapy has been established. We have asked for presentations at the symposium from various fields in order to encourage interdisciplinary collaboration in the medical treatment of Crohn's disease. Regarding treatment, basically madical treatment plays a key role. Pharmacotherapy and enteral feeding treatment are two pillars. In pharmacotherapy, 5ASA drugs and steroids play key roles. However, the dosage of immunosuppressive agents must be carefully considered because there is a problem of side effects resulting from chronic administration of steroids. And a new therapy, the target of which is a cytokine, has been developed. Enteral feeding treatment is a superior therapy, but it is hardly used in Europe and America because there is a problem with regard to maintenance of the quality of life. A dietitian gave a presentation on a method of ingesting orally administered jellied ED. According to that report, restrictions of night administration are largely decreased, and patients can take ED at schools and places of work. Therefore, this method is popular with patients. I think that we should try this method for cases in which there is no stenosis. Regarding the reason for surgical treatment, stenosis was the top reason at 70%. In 32% of the cases undergoing multiple operation, there were lesions in small intestine In addition to pharmacotherapy to avoid reoperation, the importance of enteral feeding treatment was shown. Regarding Crohn's disease, the cause is unclear. It is intractable and young people develop this disease, Therefore, I think long-term supports of patients is necessary. However, due to personnel changes of medical workers at national hospitals, difficulty in maintaining medical and psychological support sometimes results. It is assumed that this point will need to be addressed in the future.
